Taiwan FDA Approves MagQu Plasma Aβ And Tau Tests ... | 合法醫療器材資訊網

2021年2月5日—MagQuisn'ttheonlycorporationworkingonAlzheimer'sbloodtests.In2018,MastersandcolleaguesfromShimadzuCorp.unveiledamass ...

05 Feb 2021

There is an update in the world of Alzheimer’s disease blood tests. This January, the Taiwan Food and Drug Administration approved three immunoassays developed by the biotech company MagQu Co., based in New Taipei City, that measure Aβ40, Aβ42, and total tau in plasma. These products can be used to aid doctors or medical technologists in their diagnosis of Alzheimer’s disease and amnestic mild cognitive impairment, or they can be used to evaluate risk for dementia, Shieh-Yueh Yang, the president of MagQu, wrote to Alzforum. The agency’s approval categorizes the test as supportive, however; PET scans or clinical tests will still be required for a formal diagnosis.